Table 4.
Responses to Subcutaneous Alemtuzumab by Enrollment Category
| Status Before Alemtuzumab |
Total No./ No. of Responders (/) |
Total No./ No. of BM 4-Color Flow Responders (/) |
|---|---|---|
| Complete remissiona | 4/4 (100) | 0/2 (0) |
| Nodular partial remission | 8/9 (89) | 2/7 (29) |
| Partial remissionb | 11/16 (69) | 2/13 (15) |
| Not evaluable | 0/2 (0) | 0/1 (0) |
| Overall | 23/31 (74) | 4/23 (17) |
BM indicates bone marrow.
a
One patient who was not included was not evaluable for response.
b
One patient who was not included was an early death.